Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | transcription factor SMAD2 | 0.025 | 0.5871 | 0.5871 |
Echinococcus multilocularis | GPCR, family 2 | 0.0131 | 0.2871 | 0.3509 |
Loa Loa (eye worm) | hypothetical protein | 0.0283 | 0.67 | 0.67 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0242 | 0.0242 |
Schistosoma mansoni | hypothetical protein | 0.0131 | 0.2871 | 0.3509 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.025 | 0.5871 | 0.5871 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0027 | 0.0242 | 0.5 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0131 | 0.2871 | 0.3509 |
Schistosoma mansoni | tar DNA-binding protein | 0.0341 | 0.8181 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0341 | 0.8181 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0027 | 0.0242 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0341 | 0.8181 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0413 | 1 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0341 | 0.8181 | 0.8181 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0283 | 0.67 | 0.67 |
Brugia malayi | RNA binding protein | 0.0341 | 0.8181 | 0.8181 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0131 | 0.2871 | 0.3509 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0131 | 0.2871 | 0.2871 |
Loa Loa (eye worm) | hypothetical protein | 0.0413 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0131 | 0.2871 | 0.3509 |
Schistosoma mansoni | hypothetical protein | 0.0131 | 0.2871 | 0.3509 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0242 | 0.0242 |
Schistosoma mansoni | tar DNA-binding protein | 0.0341 | 0.8181 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0341 | 0.8181 | 0.8181 |
Leishmania major | hypothetical protein, conserved | 0.0027 | 0.0242 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0341 | 0.8181 | 0.8181 |
Brugia malayi | hypothetical protein | 0.0017 | 0.0004 | 0.0004 |
Schistosoma mansoni | hypothetical protein | 0.0131 | 0.2871 | 0.3509 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.0242 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.0242 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0242 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0341 | 0.8181 | 0.8181 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0131 | 0.2871 | 0.2871 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0242 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0341 | 0.8181 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.2871 | 0.2871 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0131 | 0.2871 | 0.2871 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0131 | 0.2871 | 0.3509 |
Brugia malayi | TAR-binding protein | 0.0341 | 0.8181 | 0.8181 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0413 | 1 | 1 |
Brugia malayi | MH2 domain containing protein | 0.025 | 0.5871 | 0.5871 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0027 | 0.0242 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.0131 | 0.2871 | 0.3509 |
Schistosoma mansoni | tar DNA-binding protein | 0.0341 | 0.8181 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0283 | 0.67 | 0.819 |
Schistosoma mansoni | tar DNA-binding protein | 0.0341 | 0.8181 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0131 | 0.2871 | 0.3509 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.